Systemic transthyretin amyloidosis in a patient with bent spine syndrome

References

• Shiller SM, Dogan A, Raymond KM, Highsmith WE. Laboratory methods for the diagnosis of hereditary amloidosis, in: Amyloid and related disorders: surgical pathology and clinical correlations. New York: Springer Science + Business Media LLC; 2012
   Google Scholar
• Prayson RA. Amyloid myopathy: clinicopathologic study of 16 cases. Hum Pathol 1998;29:463–8
   PubMedGoogle Scholar
• Simmons Z, Specht CS. The neuromuscular manifestations of amyloidosis. J Clin Neuromuscul Dis 2010;11:145–57
   PubMedGoogle Scholar
• Goedert M, Spillantini MG. A century of Alzheimer’s disease. Science 2006;314:777–81
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002;297:353–6
   PubMed Web of Science ®Google Scholar
• Askanas V, Engel WK. Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging. Curr Opin Rheumatol 2003;15:737–44
   PubMedGoogle Scholar
• Nadkarni N, Freimer M, Mendell JR. Amyloidosis causing a progressive myopathy. Muscle Nerve 1995;18:1016–8
   PubMedGoogle Scholar
• Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR 3rd, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 2009;114:4957–9
   PubMed Web of Science ®Google Scholar
• Chapin JE, Kornfeld M, Harris A. Amyloid myopathy: characteristic features of a still underdiagnosed disease. Muscle Nerve 2005;31:266–72
   PubMedGoogle Scholar
• Yamashita T, Ando Y, Katsuragi S, Nakamura M, Obayashi K, Haraoka K, Ueda M, et al. Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys. Muscle Nerve 2005;31:41–5
   PubMed Web of Science ®Google Scholar
• Delcey V, Hachulla E, Michon-Pasturel U, Queyrel V, Hatron PY, Boutry N, Lemaitre V, et al. [Camptocormia: a sign of axial myopathy. Report of 7 cases]. Rev Med Interne 2002;23:144–54
   PubMed Web of Science ®Google Scholar
• Friedman Y, Paul JT, Turley J, et al. Axial myopathy due to primary amyloidosis. Muscle Nerve 2007;36:542–6
   PubMedGoogle Scholar
• Koike H, Ando Y, Ueda M, Hazrati LN, Munoz D. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 2009;287:178–84
   PubMed Web of Science ®Google Scholar
• Satoskar AA, Efebera Y, Hasan A, Brodsky S, Nadasdy G, Dogan A, Nadasdy T. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing. Am J Surg Pathol 2011;35:1685–90
   PubMed Web of Science ®Google Scholar
• Devata S, Hari P, Markelova N, Li R, Komorowski R, Shidham VB. Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: role of electron microscopy and Congo red stained cell block sections. Cytojournal 2011;8:11
   PubMed Web of Science ®Google Scholar
• Klein CJ, Vrana JA, Theis JD, Dyck PJ, Spinner RJ, Mauermann ML, Bergen HR, 3rd, et al. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol 2010;68:195–9
   PubMedGoogle Scholar
• Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 1986;83:4044–8
   PubMed Web of Science ®Google Scholar
• Stein TD, Johnson JA. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 2002;22:7380–8
   PubMed Web of Science ®Google Scholar
• Li X, Masliah E, Reixach N, Buxbaum JN. Neuronal production of transthyretin in human and murine Alzheimer’s disease: is it protective? J Neurosci 2011;31:12483–90
   PubMed Web of Science ®Google Scholar
• Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, et al. Transthyretin protects Alzheimer’s mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci USA 2008;105:2681–6
   PubMed Web of Science ®Google Scholar
• Li X, Buxbaum JN. Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer’s disease? Mol Neurodegen 2011;6:79
   PubMed Web of Science ®Google Scholar
• Schwarzman AL, Tsiper M, Wente H, Wang A, Vitek MP, Vasiliev V, Goldgaber D. Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants. Amyloid 2004;11:1–9
   PubMed Web of Science ®Google Scholar